Stocks and Investing Stocks and Investing
Thu, October 22, 2020
Wed, October 21, 2020

Rick Wise Maintained (ABT) at Strong Buy with Increased Target to $120 on, Oct 21st, 2020


Published on 2024-10-27 14:26:46 - WOPRAI, Rick Wise
  Print publication without navigation


Rick Wise of Stifel, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Increased Target from $115 to $120 on, Oct 21st, 2020.

Rick has made no other calls on ABT in the last 4 months.



There are 10 other peers that have a rating on ABT. Out of the 10 peers that are also analyzing ABT, 1 agrees with Rick's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $110 on, Friday, July 17th, 2020


These are the ratings of the 9 analyists that currently disagree with Rick


  • Joshua Jennings of "TD Cowen" Maintained at Buy with Decreased Target to $113 on, Monday, October 19th, 2020
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $125 on, Friday, October 9th, 2020
  • Mike Polark of "Wolfe Research" Initiated at Buy and Held Target at $124 on, Friday, September 11th, 2020
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $136 on, Monday, August 31st, 2020
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $130 on, Friday, August 28th, 2020
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $112 on, Thursday, August 27th, 2020
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Thursday, August 27th, 2020
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $125 on, Thursday, July 23rd, 2020
  • John Sourbeer of "UBS" Maintained at Strong Buy with Increased Target to $110 on, Friday, July 17th, 2020
Contributing Sources